Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
Boston University
Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
A diagnosis of social communication disorder only keeps people from a community and resources they desperately want and need.
Studying parents of children with autism has long been controversial, but that doesn’t mean scientists should avoid it.
Elsa, the star of the movie “Frozen,” is the poster child for girls with autism.
Scientists should slow down and return to the basic tenets of research to regain the public’s trust.
Trials to test drugs for autism suffer from subjective measurements and placebo effects. Helen Tager-Flusberg outlines how to ferret out the true effects of potential autism therapies.
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
At the 25th annual meeting of the International Society for Autism Research, scientists, clinicians and self-advocates gathered to discuss topics such as autism genetics and the gap between clinical trials and real-world benefits.
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”
In an open letter, scientists call the ERC’s suggestion to block grant reapplications for an additional year “at odds with scientific excellence.”